DNLI vs LIFE: stock comparison and AI forecast
Denali Therapeutics Inc. (DNLI) and Atyr Pharma Inc (LIFE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DNLI Denali Therapeutics Inc.
- Market Cap
- $3.03B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
LIFE Atyr Pharma Inc
- Market Cap
- $2.72B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- DNLI is 1.1 times larger than LIFE by market capitalization ($3.03B against $2.72B).
- DNLI turns -14191.2% of its revenue into net income, against -32003.7% for LIFE.
- LIFE carries 0.44 times debt per unit of equity, against 0.39 times for DNLI.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DNLI | LIFE |
|---|---|---|
| Market Cap | $3.03B | $2.72B |
| P/B Ratio | 3.62x | 55.77x |
| EPS | $-2.93 | $-0.69 |
| Book Value/Share | $5.22 | $0.76 |
| FCF/Share | $-2.74 | $-0.86 |
Profitability & Margins
| Metric | DNLI | LIFE |
|---|---|---|
| ROE | -61.2% | -124.6% |
| ROA | -44.2% | -87.1% |
| ROIC | -50.8% | -109.3% |
| Operating Margin | -15058.2% | -33609.5% |
| Net Margin | -14191.2% | -32003.7% |
| EBT Margin | -15058.2% | -31765.3% |
| Tax Rate | -0.0% | – |
Financial Health
| Metric | DNLI | LIFE |
|---|---|---|
| Current Ratio | 8.37x | 5.12x |
| Quick Ratio | 8.32x | – |
| D/E Ratio | 0.39x | 0.44x |
| Financial Leverage | 1.39x | 1.43x |
| Interest Coverage | – | -837.0x |
| Working Capital | $664M | $47M |
Cash Flow
| Metric | DNLI | LIFE |
|---|---|---|
| Operating Cash Flow | -$434M | -$55M |
| Free Cash Flow | -$437M | -$55M |
| Capital Spending | -$3M | -$280K |
Income Statement
| Metric | DNLI | LIFE |
|---|---|---|
| Operating Income | -$543M | -$64M |
| Net Income | -$511M | -$61M |
| R&D Expense | $401M | $47M |
Dividend & Shareholder Information
| Metric | DNLI | LIFE |
|---|---|---|
| Shares Outstanding | 160M | 64M |
DNLI vs LIFE: stock comparison and AI forecast
Which is bigger, DNLI or LIFE?
DNLI is 1.1 times larger than LIFE by market capitalization ($3.03B against $2.72B).
Which one does Intratio's AI model rank higher, DNLI or LIFE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.